15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages

Biochimica Et Biophysica Acta
Angela PirilloAlberico Luigi Catapano

Abstract

Elevated plasma levels of high-density lipoprotein cholesterol (HDL-C) are atheroprotective and HDL-dependent reverse cholesterol transport has been related to this effect. HDL particles may, however, undergo modifications that affect their biological activities. Lipoxygenases (LOs) belong to a family of lipid peroxidizing enzymes; among them, reticulocyte-type 15-lipoxygenase (15-LO-1) appears to play a pathophysiological role in atherosclerosis, as its expression is increased in atherosclerotic plaques and it has been shown to oxidize low-density lipoproteins to an atherogenic form. In this work we investigated the impact of in vitro 15-lipoxygenase-catalyzed modification of HDL3 on their ability to act as cholesterol acceptor and found that 15-LO-modified HDL3 were less effective in mediating cholesterol efflux from lipid-laden J774 cells. A reduced binding of 15-LO-modified HDL3 to scavenger receptor class B, type I (SR-BI), due to HDL apoproteins cross-linking, explained, at least in part, the observed reduction of cholesterol efflux. In addition, ATP-binding cassette transporter A1 (ABCA1)-mediated cholesterol efflux was also reduced, as a consequence of pre-beta-particles loss after HDL3 modification. These results sugge...Continue Reading

Citations

Jan 14, 2011·The New England Journal of Medicine·Menno VergeerJan Albert Kuivenhoven
Aug 15, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Jonathan D Smith
Nov 15, 2011·Lipids in Health and Disease·Jian-Kai ZhongYan Tu
Apr 8, 2010·Journal of Lipid Research·Menno VergeerJan Albert Kuivenhoven
Oct 18, 2012·Biochemical and Biophysical Research Communications·Angela PirilloAlberico Luigi Catapano
Sep 18, 2007·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Jonas Wittwer, Martin Hersberger
Jul 19, 2014·Atherosclerosis·Chandrakala Aluganti NarasimhuluSampath Parthasarathy
Nov 26, 2010·Biochemical and Biophysical Research Communications·Angela PirilloAlberico L Catapano
Oct 16, 2014·Biochimica Et Biophysica Acta·Hartmut KuhnKlaus van Leyen
Jan 22, 2015·International Journal of Molecular Medicine·Chen LiWen-Yan Lai
Oct 26, 2010·Progress in Lipid Research·Anca D DobrianJerry L Nadler
May 11, 2016·The Journal of Steroid Biochemistry and Molecular Biology·M TafelmeierG Schmitz
May 17, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Gemma BrufauFolkert Kuipers
Jan 16, 2007·Current Opinion in Lipidology·Jillian Davidson, Dino Rotondo
Jun 1, 2018·Current Medicinal Chemistry·Angela PirilloGiuseppe Danilo Norata
Sep 2, 2011·Current Opinion in Lipidology·Miriam Lee-Rueckert, Petri T Kovanen
Aug 8, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angela PirilloAlberico Luigi Catapano
Nov 26, 2018·Progress in Lipid Research·Nikhlesh K Singh, Gadiparthi N Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.